EP1339717B1
(de)
|
|
Neue carbamat-substituierte pyrazolopyridinderivate
|
EP1339716B1
(de)
|
|
lactam-substituierte pyrazolopyridinderivate
|
US3818035A
(en)
|
|
2{8 (2-ALKYLBENZO{8 b{9 {11 FURAN-3 yl)METHYL{9 -{66 {11 IMIDAZOLINE
|
JPS60226882A
(ja)
|
|
新規ピリミドピリミジン誘導体
|
JPS61257951A
(ja)
|
|
新規なアリ−ル誘導体
|
WO2003086407A1
(de)
|
|
Verwendung von stimulatoren der löslichen guanylatcyclase zur behandlung von glaukom
|
US10323044B2
(en)
|
|
Crystal of imidazo-oxazine, pharmaceutical composition containing said crystal, and method for producing said crystal
|
CN111410661A
(zh)
|
|
帽依赖性内切核酸酶抑制剂及其用途
|
JPS6284052A
(ja)
|
|
〔(2,3,9,9a‐テトラヒドロ―3‐オキソ‐9a‐置換‐1H‐フルオレン―7‐イル)オキシ〕エタンイミドアミド類、〔(2,3,9,9a‐テトラヒドロ‐3‐オキソ‐9a‐置換‐1H‐フルオレン‐7‐イル)オキシ〕エタンイミド酸ヒドラジド類その誘導体および塩
|
DE69914614T2
(de)
|
|
Ungesättigte hydroximsäurederivate als parp inhibitoren
|
US20040063948A1
(en)
|
|
Crystalline fluoroquinolone arginine salt form
|
SK2722002A3
(en)
|
|
Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia
|
EP1560818A1
(en)
|
|
Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
|
CN111166745A
(zh)
|
|
含消旋氧吡格雷或其盐的组合物及应用
|
JPS62190184A
(ja)
|
|
8α−アクリルアミノエルゴリン、その製造方法および該化合物を含有する医薬組成物
|
CN113387909B
(zh)
|
|
2,3-环氧丁二酰衍生物的医药用途
|
SE175504C1
(ko)
|
|
|
EP0000693B1
(de)
|
|
Aminophenoxymethyl-2-morpholinderivate, ihre Herstellung und sie enthaltende Arzneimittel
|
HU196069B
(en)
|
|
Process for production of 8-/dihydropiridil-carbamoiloxi-methil/-ergolines and medical compounds containing these compositions
|
JPS61158980A
(ja)
|
|
8α‐アシルアミノエルゴリン類、その製法および医薬組成物
|
WO2006088080A1
(ja)
|
|
シクロヘプタ[b]ピリジン-3-カルボニルグアニジン誘導体およびそれを含有する医薬品
|
US4755601A
(en)
|
|
Nonyl prenyl-N heterocyclics
|
DE69809891T2
(de)
|
|
Nitro-benzamid verwendbar als antiarrythmica
|
US3073740A
(en)
|
|
Method of reducing cholesterol levels with tri- (dialkylaminoalkyl) phosphates
|
EP3868768A1
(en)
|
|
Pharmaceutical crystal of contezolid acefosamil, preparation method therefor, and uses thereof
|